CHARLOTTESVILLE, Va., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today announced that Purnovate, Inc., a subsidiary of Adial ...
Polynovo Ltd. Annual stock financials by MarketWatch. View the latest PNV financial statements, income statements and financial ratios.
PolyNovo Limited (ASX:PNV), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the ASX over the last few months. Shareholders may appreciate the ...
At close: 24 December at 2:10:09 pm AEDT ...
PolyNovo (ASX:PNV) has had a rough three months with its share price down 15%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially ...
Purnovate Inc., a subsidiary of Adial Pharmaceuticals Inc., has achieved promising in vivo data for PNV-5030 as a potential treatment for chronic pain. The study was conducted in four groups of 10 ...
As of 12:20:32 pm AEDT. Market open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback